Enterobacter hormaechei was first identified as a unique species in 1989. Between 29 November 1992 and 17 March 1993, an outbreak of E. hormaechei occurred among premature infants in the intensive care nursery (ICN) at The Hospital of the University of Pennsylvania. The 10 infants whose cultures were positive for E. hormaechei (six were infected and four were colonized) had a lower median estimated gestational age and birth weight than did other ICN infants; other risk factors for infection or colonization with E. hormaechei were not identified. Cultures from three isolettes and a doorknob in the ICN were positive for E. hormaechei. Pulsed-field gel electrophoresis of isolates from six patients and two isolettes were identical. Observations of health care workers revealed breaks in infection control techniques that may have allowed transmission of this organism. We found that E. hormaechei is a nosocomial pathogen that can infect vulnerable hospitalized patients and that can be transmitted from patient to patient when infection control techniques are inadequate.
Enterobacter hormaechei was first identified as a unique ing through a 0.45-m filter, and placing the filter on MacConkey agar. species in 1989 [1] . In this initial report, most clinical isolates came from blood, wounds, or sputum. Additional reports of Available E. hormaechei isolates were sent to the Centers for Disease Control and Prevention (CDC; Atlanta) for conclinical infection due to this organism have not been published. We report an outbreak of E. hormaechei among premature firmation and identification by standard biochemical tests and the API 20E system (bioMérieux Vitek, Hazelwood, MO), antiinfants in an intensive care nursery (ICN) at a tertiary care hospital.
microbial susceptibility testing, and pulsed-field gel electrophoresis.
Methods

Results
A case-patient was defined as any patient in The Hospital
The ten case-patients had a median estimated gestational age of the University of Pennsylvania ICN between 29 November of 26 weeks (range, 24 -28 weeks) and a median birth weight 1992 and 17 March 1993 (the epidemic period) whose culture of 762 g (range, 662 -1,1130 g); the median age at the first was positive for E. hormaechei (specimen from any site). Risk positive culture for E. hormaechei was 16 days (range, 3 -67 factors were evaluated in a cohort study of all ICN patients days). Six case-patients were female, and nine were black. during the epidemic period. Medians were compared with Wil-E. hormaechei was isolated from the blood of five infants, from coxon's rank sum test, and proportions were compared with tracheal aspirates from five infants, from the nasopharynx of Fisher's exact test.
six infants, and from the rectum of ten infants. Six case-patients On 16 -17 March 1993, we cultured ICN tap water, isolette were considered to be infected (five with bloodstream infection, tops and ports, doorknobs, and health care workers' hands.
and one with tracheitis), and four were considered to be coloHand cultures were obtained by wiping hands with a sterile nized. Of the six infected case-patients, four were treated with cloth, adding Tween 80 solution, shaking for 20 minutes, filtervancomycin, netilmicin, and cefotaxime; one was treated with netilmicin and cefotaxime; and one was treated with netilmicin alone. The cohort study included 10 case-patients and 197 control E. hormaechei, and E. hormaechei was not considered to have changed from ampicillin and gentamicin to ampicillin and cefotaxime or ampicillin and ceftazidime. E. hormaechei colonizacontributed to the patient's death. tion was diagnosed in the last case-patient on 17 March 1993. Since all case-patients had a birth weight of £1,500 g and In July 1993, empirical therapy was changed back to ampicillin an ICN stay of §3 days at the time of the first positive culture, and gentamicin. As of October 1996, no additional infants a subgroup of ICN patients with a birth weight of £1,500 g whose cultures were positive for E. hormaechei had been idenand an ICN stay of §3 days was analyzed. In this subgroup, tified. the median birth weight was lower among the 10 cases than among the 16 control infants, but the difference was not statistically significant (762 vs. 940 g, P Å .2). Discussion All 26 infants were placed on assisted ventilation, given iv Risk factors for infection with Enterobacter species include fluids through umbilical arterial and/or venous catheters, and being immunosuppressed, having a significant underlying illtreated empirically with ampicillin and gentamicin; therefore, ness, having an indwelling catheter or having undergone a these therapies were not found to be significant risk factors for recent invasive procedure, receiving care in an intensive care E. hormaechei infection or colonization. In addition, infants unit, and receiving antimicrobials [3, 4] . Enterobacter species who had an endotracheal tube or umbilical arterial or venous have been implicated in both point-source outbreaks and outcatheter placed in the delivery room were not at higher risk breaks caused by patient-to-patient transmission via the hands for E. hormaechei infection or colonization than were those of hospital personnel [3, 5] . Enterobacter cloacae and Enterowho underwent placement in the ICN.
bacter aerogenes are the Enterobacter species most commonly Microbiology. All E. hormaechei isolates were resistant to associated with human disease [6] . Enterobacter sakazakii was ampicillin and gentamicin. Isolates from the six infected infants implicated in a neonatal intensive care unit outbreak traced to were susceptible to aztreonam, ceftazidime, ceftriaxone, cicontaminated commercial powdered infant formula [7] . profloxacin, imipenem, and trimethoprim-sulfamethoxazole; all
The outbreak of E. hormaechei infection and colonization isolates were resistant to cephalothin, piperacillin, and tobradescribed herein occurred among vulnerable, low-birth-weight mycin; one of six isolates was resistant to netilmicin, and none premature infants. Environmental contamination and lapses in of three tested were resistant to amikacin.
infection control may have facilitated transmission from patient Cultures from the hands of 4 (18%) of 22 ICN personnel to patient by health care workers. Resistance to ampicillin and were positive for Enterobacter species, but none of these isogentamicin, the antimicrobials used to empirically treat infants lates were identified as E. hormaechei. Of the 25 water or with suspected sepsis in this ICN, may have enabled E. horenvironmental surface cultures, E. hormaechei was isolated maechei to become epidemic. The outbreak ended after case-(from broth only) from the tops of three isolettes and one doorpatients were isolated from other infants, adherence to infection knob. All environmental (n Å 2) and case-patient (n Å 6) control practices was increased, cleaning of environmental sur-E. hormaechei isolates that were typed had identical pulsedfaces was enhanced, and empirical antimicrobial coverage was field gel electrophoresis DNA banding patterns.
changed. Infection control practices. Most medications were prepared in the pharmacy; medications prepared in the ICN were used in single-dose vials. Space allocation per ICN patient
